Special ArticlesThe International Society of Urological Pathology Consultation on Molecular Pathology of Urogenital Cancervan der Kwast, Theodorus H. MD, PhD*; Egevad, Lars MD†; Kristiansen, Glen MD‡; Grignon, David J. MD§Author Information *Laboratory Medicine Program, University Health Network, Toronto, ON, Canada †Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden ‡Institute of Pathology, University Hospital Bonn, Germany §Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Correspondence: Theodorus H. van der Kwast, MD, PhD, Department of Pathology, Toronto General Hospital, 11-E220, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4 (e-mail: firstname.lastname@example.org). The American Journal of Surgical Pathology: July 2020 - Volume 44 - Issue 7 - p 859-861 doi: 10.1097/PAS.0000000000001496 Buy Metrics Abstract The 2019 Consultation Conference on the molecular pathology of urogenital cancers was organized by the International Society of Urological Pathology (ISUP) to have an understanding of the current use of molecular-genetic markers and to make recommendations on their application in prostate, bladder, renal, testicular, and penile cancer. This brief introductory article describes the organization of this conference and provides its rationale and main findings. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.